Lilani Perera, MD,AGAF, FCCF 
Director, Crohn’s & Colitis Program
Division of Gastroenterology | Boston Medical Center
Clinical Associate Professor of Medicine
Boston University Chobanian & Avedisian School of Medicine
Boston, MA

Dr. Lilani Perera is a distinguished gastroenterologist specializing in inflammatory bowel disease (IBD) and serving as the Director of the Crohn’s & Colitis Program at Boston Medical Center. She is also an Associate Clinical Professor of Medicine at Boston University. Dr. Perera graduated with honors from the University of Colombo, completed her fellowships in gastroenterology at Medical College of Wisconsin and IBD immunology research fellowship at Mount Sinai Medical Center, NY. Her career includes significant roles at the Medical College of Wisconsin, Advocate Aurora Health, and Tufts Medical Center, where she developed comprehensive IBD programs. She is actively involved in national organizations like the American Gastroenterological Association and the Crohn's and Colitis Foundation, focusing on patient education and gender equity.

Dr. Perera has no relevant financial relationships to disclose.

Off-Label Discussion: The speaker does not plan on discussing unlabeled/investigational uses of a commercial product.

Planning Committee

The following planning committee members have no relevant financial relationships to disclose.

• Linda Baer, MSPH, CHCP; BU CCE Associate Director
• Juanita Belton, PA; Physician Associate Accreditation Reviewer
• Michael Burk, BS; BU CCE Senior Operations Manager
• Amy Donegan , APRN, CPNP-PC; Member of the BU Hub Team and Nursing Accreditation Advisor
• Sharmeel Wasan, MD; Program Course Director

Dr. Spiewak, PharmD, MCSR-RPh, MSCS; ACPE Accreditation Advisor, discloses that he is a speaker, consultant, and on the advisory panels for Abbvie, Celltrion, and Johnson & Johnson.

Disclosure Policy

Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. 
 

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships that faculty, planners, authors, and anyone who may be in control of content have with ineligible companies have been mitigated.
 

Disclaimer Policy

THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS.  ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE.  TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS.  IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS.  IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.  IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.